Erratum: Expression of Ki-67, transforming growth factor β1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases (Journal of Gastroenterology and Hepatology 21, (700-710) DOI: 10.1111/j.1440-1746.2006.04149.x);Expression of Ki-67, transforming growth factor β1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 4, 2006, Pages 700-710

  Piekarska, Anna ^a   Piekarski, Janusz ^a   Szymczak, Wiesław ^a   Kubiak, Robert ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Chronic hepatitis; Fibrosis; Proliferation

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALCOHOL LIVER DISEASE; ANALYTIC METHOD; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BILE DUCT; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE; STATISTICAL SIGNIFICANCE; STROMA CELL;

EID: 33645873286     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05144.x     Document Type: Erratum

References (52)

1. Kronenberger B Ruster B Lee JH et al. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. J. Hepatol. 2000 33 640 7.
2. Donato MF Arosio E Del Ninno E et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 2001 34 523 8.
3. Gerdes J Lemke H Baisch H Wacker HH Schwab U Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 1984 133 1710 15.
4. Gerlach C Sakkab DY Scholzen T Dassler R Alison MR Gerdes J. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology 1997 26 573 8.
5. Dutta U Kench J Byth K et al. Hepatocellular proloferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C. Hum. Pathol. 1998 29 1279 84.
6. Kang YK Hong SW Lee H Kim WH. Overexpression of clusterin in human hepatocellular carcinoma. Hum. Pathol. 2004 35 1340 6.
7. Moginaga S Nakamura Y Ishiwa N et al. Expression of surviving mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Oncol. Rep. 2004 12 1189 94.
8. Kaita KDE Pettigrew N Minuk GY. Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissues. Liver 1997 17 13 16.
9. Matsumoto K Tanimoto K Michitaka K et al. Detection of Ki-67 in liver biopsy specimens using monoclonal antybody to Mib-1. Rinsho Byori 1999 47 956 60A.
10. Derynck R Akhurst R Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 2002 29 117 29.
11. Akhurst R Derynck R. TGF-β signaling in cancer: a double edged sword. Trends Cell Biol. 2001 11 S44 51.
12. Wakefield L Roberts A. TGF-β signaling: positive and negative effects on tumorogenesis. Curr. Opin. Genet. Dev. 2002 12 22 9.
13. Akhurst R. TGF-β antagonists: why supress a tumor supressor? J. Clin. Invest. 2002 109 1533 6.
14. Border W Noble N. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 1994 331 1286 92.
15. Nakamura T Tomita Y Hirai R Yamaoka K Kaji K Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 1985 133 1042 50.
16. Crary GS Albrecht JH. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998 28 738 43.
17. Murata T Ohshima T Yamaji M et al. Suppression of hepatitis C virus replicon by TGF-beta. Virology 2005 331 407 17.
18. Xu XB Leng XS Yang X He ZP. Obstruction of TGF-beta1 signal transduction can decrease the process of hepatocellular carcinoma in mice induced by CCl4/ethanol. Zhonghua Yi Xue Za Zhi 2004 84 1122 5.
19. Kakonen SM Selander KS Chirgwin JM et al. TGF-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 2002 277 24 71 8.
20. Muraoka RS Dumont N Ritter CA et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration and metastases. J. Clin. Invest. 2002 109 1551 9.
21. Bedossa P Peltier E Terris B Franco D Poynard T. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995 21 760 6.
22. Miyafuji Y Zhong X Uchida I Koi M Hemmi H. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells. J. Cell Physiol. 2001 187 356 64.
23. Charlotte F L'Hermine A Martin N et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am. J. Pathol. 1994 144 460 5.
24. Desmouliere A Redard ID Gabbini G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 1995 146 56 66.
25. Neuman MG. Apoptosis in diseases of the liver. Crit. Rev. Clin. Lab. Sci. 2001 38 109 66.
26. Xiao-Ming Y. Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes. J. Mol. Med. 2000 78 203 11.
27. Gross AJ McDonnell M Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 1999 13 1899 911.
28. Scheuer JP. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 1991 13 372 4.
29. Farinati F Cardin R D'Errico A et al. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 1996 23 1468 75.
30. Floreani A Guido M Bortolami M et al. Relationship between apoptosis, tumor necrosis factor, and cell proliferation in chronic cholestasis. Dig. Liver Dis. 2001 33 570 5.
31. Kawakita N Seki S Yanai A et al. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/Cyclin). Am. J. Clin. Pathol. 1992 97 Suppl. 1 S14 20.
32. Bottelli R Veronese S Iamoni G. S bromodeoxyuridine proliferation index and long term prognosis in hepatocellular carcinoma. Hepatology 1993 18 181A.
33. Clark SA Angus HB Cook HB George PM Oxner RB Fraser R. Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet 1988 21 1225 7.
34. Neuman MG Benhamou JP Malkiewicz IM et al. Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J. Viral Hepat. 2002 9 134 40.
35. Deng I Zhou Y Peng X Deng H Deng Y Yao J. Serum markers and pathological evaluation of hepatic fibrosis of chronic hepatitis B treated with interferon alpha. Zhonghua Gan Zang Bing Za Zhi 2001 9 Suppl. 1 66 7A.
36. Calabrese F Valente M Giacometti C et al. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J. Gastroenterol. Hepatol. 2003 18 1302 8.
37. Nelson DR Gonzales-Peralta RP Qian KP et al. Transforming growth factor-β1 in chronic hepatitis C. J. Viral Hepat. 1997 4 29 35.
38. Kanzler S Baumann M Schirmacher P et al. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β. J. Viral Hepat. 2001 8 430 7.
39. Abou-Shady M Friess H Zimmermannn A et al. Connective tissue growth factor in human liver cirrhosis. Liver 2000 20 296 304.
40. Flisiak R Maxwell P Prokopowicz D Timms PM Panasiuk A. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1: possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepatogastroenterology 2002 49 1369 72.
41. Castilla A Prieto J Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effect of interferon alfa therapy. N. Engl. J. Med. 1991 324 933 40.
42. Malizia G Brunt EM Peters MG Rizzo A Broekelmann TJ McDonald JA. Growth factor and procollagen type 1 gene expression in human liver disease. Gastroenterology 1995 108 145 56.
43. Banner BF Allan C Savas L Baker S Barnard G Bonkovsky HL. Inflammatory markers in chronic hepatitis C. Virchows Arch. 1997 431 181 7.
44. Powell EE Edwards-Smith CJ Hay JL et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000 31 828 33.
45. Kim HG Chung YH Song BC et al. Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection. Korean J. Intern. Med. 2000 15 165 70.
46. Tsamadas AC Thomopoulos K Zalota V et al. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Mod. Pathol. 2003 16 1273 88.
47. Gabriel A Ziołkowski A Dziambor AP Radłowski P Kropczynski G. Bcl-2 antigen expression in patients with chronic hepatitis C and advanced fibrosis. Med. Sci. Monit. 2001 7 Suppl. 1 181 4.
48. Chou AH Tsai HF Wu YY et al. Hepatitis C virus core protein modulates trail-mediated apoptosis by enhancing bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 2005 174 2160 6.
49. Otsuka M Kato N Taniguchi H Yoshida H Schiratori Y Omata M. Hepatis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Virology 2002 296 84 93.
50. Ehrmann J Galuszkova D Ehrmann J et al. Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection. Pathol. Oncol. Res. 2000 6 130 5.
51. Kim JS Ryu J Hwang SB Lee SY Choi SY Park J. Suppression of ceramide-induced cell death by hepatitis C virus core protein. J. Biochem. Mol. Biol. 2004 37 192 8.
52. Tsamadas AC Thomopoulos K Gogos C et al. Expression of bcl-2 oncoprotein in cases of acute and chronic viral hepatitis type B and type C: a clinicopathologic study. Dig. Dis. Sci. 2002 47 1618 24.